Evaluation of vascular smooth muscle and corpus cavernosum on hypercholesterolemia. Is resveratrol promising on erectile dysfunction?

被引:0
作者
B C Soner
N Murat
O Demir
H Guven
A Esen
S Gidener
机构
[1] Medical Faculty,Department of Pharmacology
[2] Dokuz Eylul University,Department of Urology
[3] Advanced Professional School of Health Sciences,undefined
[4] Dokuz Eylül University,undefined
[5] Medical Faculty,undefined
[6] Dokuz Eylul University,undefined
来源
International Journal of Impotence Research | 2010年 / 22卷
关键词
corpus cavernosum; resveratrol; erectile dysfunction;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of this study is to evaluate the effects of hypercholesterolemia in thoracic aorta (TA), mesenteric artery (MA), renal artery (RA), and corpus cavernosum (CC) isolated from cholesterol-fed rabbits. For determination of the maximum detrimental effect, vasorelaxation and vasoconstriction results of arteries and CC have been compared. Animals were fed with a diet that contained 2% w/w cholesterol and 2% w/w high cholesterol plus resveratrol (4 mg kg–1 per day) for 6-week duration. Total cholesterol levels in the plasma were measured. Vascular and endothelial functions in RA, TA, MA, and CC were assessed by isolated tissue bath with cumulative doses of acetylcholine and sodium nitroprusside. The statistical significance of differences of groups was analyzed by means of one-way ANOVA or Student's t-test. P-values <0.05 were considered significant. There have been no significant changes on plasma total cholesterol levels between cholesterol and cholesterol + resveratrol-treated groups. Vasorelaxation responses to acetylcholine in resveratrol-treated group showed significant changes when compared with hypercholesterolemic group. No statistically significant differences were seen between non-receptor-mediated vasorelaxation responses between the three groups. Resveratrol might be an effective treatment in the prevention of atherosclerotic changes in arteries and CC. The initial effects of hypercholesterolemia on erectile dysfunction and endothelial dysfunction may be precluded with resveratrol. This protective effect may also ensure the prevention of coronary arterial diseases and renovascular diseases in hypercholesterolemic patients.
引用
收藏
页码:227 / 233
页数:6
相关论文
共 124 条
[1]  
Montorsi F(2003)Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease Eur Urol 44 360-364
[2]  
Briganti A(2003)Erectile dysfunction in the cardiac patient: how common and should we treat? J Urol 170 46-50
[3]  
Salonia A(2003)Relation of erectile dysfunction to angiographic coronary artery disease Am J Cardiol 91 230-231
[4]  
Rigatti P(2006)Prediction of coronary heart disease by erectile dysfunction in men referred for nuclear stress testing Arch Intern Med 166 201-206
[5]  
Margonato A(2005)Is erectile dysfunction an indicator for increased risk of coronary heart disease and stroke? Eur Urol 48 512-518
[6]  
Macchi A(2004)Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients Circulation 110 22-26
[7]  
Kloner RA(2005)Prevalence of asymptomatic coronary artery disease in men with vasculogenic erectile dysfunction: a prospective angiographic study Eur Urol 48 996-1002
[8]  
Mullin SH(1999)Lowering LDL-cholesterol: questions from recent analysis of clinical trials. Data from the Interdisciplinary Council of Reducing the Risk for Coronary Heart Disease Circulation 99 1-7
[9]  
Shook T(2008)Drugs designed to improve endothelial function: effects on erectile dysfunction Curr Pharm Des 14 3758-3767
[10]  
Matthews R(2006)Pharmacogenomics of cholesterol-lowering therapy Vascul Pharmacol 44 75-89